LIVER HEMANGIOSARCOMA: VENOUS MDCT (venous perfusion phase and focused portal perfusion: fig. 3)

Progressive enhancement of the solid portions of all lesions (hepatic and left kidney). Persistent contrast exclusion both necrotic areas and thin stromal and vascular scaffold.
Discrete increase in throughput/perfusion time of the mesenteric and portal venous axes. Normal patency of splenic, mesenteric and portal vein that appears to be slightly larger (hemodynamic overload drainage due to arterial/venous shunt ).